2 completed, 1 active not recruiting. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 2, Active not recruiting 1 |
Follow Graft Versus Host Disease: new trials by email Literature Review of Graft Versus Host Disease trials Research Report on Graft Versus Host Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| CINC424A2X01B Rollover Protocol ruxolitinib, panobinostat - Primary Myelofibrosis, Polycythemia Vera | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 279 | 2015-03-05 | 2026-10-19 |
| Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor Prograf, Methotrexate, Cyclosporine - Graft Versus Host Disease | Phase 4 | Completed | Astellas Pharma Korea, Inc. | 39 | 2008-02-01 | 2016-03-01 |
| Bone Marrow Transplantation in Treating Patients With Hematologic Cancer anti-thymocyte globulin, filgrastim, cyclophosphamide - Anemia, Graft Versus Host Disease | Phase 4 | Completed | University of Maryland, Baltimore | 45 | 1998-09-01 | 2019-10-17 |
Graft vs Host Disease (3) · Leukemia, Myeloid, Acute (2) · Anemia (1) · Blast Crisis (1) · Bronchiolitis Obliterans Syndrome (1) · Burkitt Lymphoma (1) · Dendritic Cell Sarcoma, Interdigitating (1) · Hodgkin Disease (1) · Leukemia (1) · Leukemia, Basophilic, Acute (1) · Leukemia, Eosinophilic, Acute (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Megakaryoblastic, Acute (1) · Leukemia, Myeloid, Accelerated Phase (1) · Leukemia, Myeloid, Chronic-Phase (1)
Immune System Diseases (3) · Bone Marrow Diseases (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Leukemia, Myeloid (2) · Myeloproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Anemia (1) · Anemia, Hemolytic (1) · Anemia, Hemolytic, Congenital (1) · Blood Protein Disorders (1) · Bone Marrow Neoplasms (1) · Bronchial Diseases (1) · Bronchiolitis (1)
Antilymphocyte Serum (1) · Cyclophosphamide (1) · Cyclosporine (1) · Filgrastim (1) · Methotrexate (1) · Panobinostat (1) · Radiotherapy (1) · Tacrolimus (1) · Thiotepa (1) · ruxolitinib (1)
Astellas Pharma Korea, Inc. (1) · Novartis Pharmaceuticals (1) · University of Maryland, Baltimore (1)
South Korea (2) · Australia (1) · Belgium (1) · Bulgaria (1) · Canada (1) · Chile (1) · China (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · India (1) · Israel (1) · Italy (1) · Japan (1)
2014 (1)